Top 20 of Hemolysis

Article title # Publications/# Citations

The fluid mosaic model of the structure of cell membranes.

1972: GLNicolson; SJSinger;

783

Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen.

1969: KLPratt; MBRittenberg;

355

Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus.

1974: PWChoppin; AScheid;

231

Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

1966: IGigli; JJensen; RANelson; NTamura;

225

Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

2002: ROCannon; MTGladwin; NHogg; CDReiter; ANSchechter; JETanus-Santos; XWang;

202

The organization of proteins in the human red blood cell membrane. A review.

1974: TLSteck;

200

Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions.

1974: MPSheetz; SJSinger;

198

Multiplication of Shigella flexneri within HeLa cells: lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis.

1986: PClerc; ATMaurelli; JMounier; ARyter; PJSansonetti;

188

Simplified scheme for routine identification of human Staphylococcus species.

1975: WEKloos; KHSchleifer;

186

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

2004: WCBlackwelder; BBrown; OCastro; WAColes; IErnst; MTGladwin; LAHunter; MLJison; ... KMinter; JSNichols; FPOgnibene; JFPlehn; GPRodgers; VSachdev; ANSchechter; YShizukuda;

184

ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

1965: HJMUELLER-EBERHARD; URNilsson;

162

The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease.

2005: LBell; MTGladwin; PHillmen; RPRother;

156

Third component of human complement: purification from plasma and physicochemical characterization.

1976: JWPrahl; BDTack;

150

Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice.

1994: PSoriano;

147

Biological effects of cyclosporin A: a new antilymphocytic agent.

1976: JFBorel; CFeurer; HUGubler; HStähelin;

140

Inhibition of Bax channel-forming activity by Bcl-2.

1997: BAntonsson; ABernard; LBernasconi; ACiavatta; FConti; FGambale; SLewis; IMartinou; ... JCMartinou; KMaundrell; GMazzei; JJMermod; SMontessuit; RSadoul;

140

Thymus-marrow cell combinations. Synergism in antibody production.

1966 Aug-Sep: EAChaperon; HNClaman; RFTriplett;

140

Studies on the mechanism by which cyanine dyes measure membrane potential in red blood cells and phosphatidylcholine vesicles.

1974: JFHoffman; PJSims; ASWaggoner; CHWang;

137

Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.

1970: BSAikin; CGCochrane; HJMüller-Eberhard;

127

In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis.

2003: BAhlemeyer; DFischer; TKissel; JKrieglstein; YLi;

124